Cystic fibrosis (CF) is one of the most common inherited childhood diseases, with about 10 million carriers in the USA alone. The disease is caused by mutation of the CFTR gene, which encodes an ion channel critical for salt homeostasis of several polarized epithelial tissues including the lung, intestine, pancreas and kidney. Disturbed salt homeostasis in patients with CF leads to impaired clearance of mucus from the respiratory tract, subsequent chronic lung infections and inflammation, and eventual respiratory failure 1, 2 . The most prevalent mutation, occurring in more than 70% of patients, is an in-framedeletion of phenylalanine 508 (refs 3, 4) . Although the ∆F508 CFTR protein is in principle a functional anion channel, the protein is unstable and rapidly degraded, leading to an almost complete loss of CFTR channel function 1, [5] [6] [7] [8] [9] [10] . Although both control (hereafter referred to as wild type, WT) and ∆F508 CFTR exhibit almost identical folds, the folding of ∆F508 CFTR is kinetically impaired, resulting in an increased recruitment of different chaperones 11 . CF is therefore also characterized as a protein misfolding disease. Up to 90% of ∆F508 CFTR protein is retained in the endoplasmic reticulum (ER) and subsequently targeted for proteolytic degradation by the ER-associated degradation pathway (ERAD) 8, 10, 12 . However, ∆F508 CFTR function can be partly rescued by a shift to lower temperature (26-30 °C) 9 or inhibition of histone deacetylases (HDACi) 13, 14 . It is therefore likely that post-translational processes, such as altered chaperone recruitment, are critical for manifestation of CF. Accordingly, models have been proposed in which differential protein interactions with ∆F508 CFTR contribute to loss of function, but are favourably altered by temperature shift or HDACi 11 . Yet relatively few proteins have been identified that interact with and participate in CFTR processing, in particular in bronchial epithelial cells, and it is largely unknown which interactions lead to ∆F508 CFTR stabilization and partial restoration of channel activity observed upon shift to permissive temperature or HDACi.
∆F508 CFTR mutation-specific interactome
To identify interactions that potentially drive the disease phenotype, we developed co-purifying protein identification technology (CoPIT), an immunoprecipitation (IP)-based proteomic-profiling approach of protein-protein interactions across different sample conditions. Using CoPIT, which increased CFTR yield by 30-to 100-fold, we first determined the changes that occur between the WT and ∆F508 CFTR interactome in isogenic HBE41o− (WT CFTR) and CFBE41o− (∆F508 CFTR) bronchial epithelial cell lines derived from a patient with CF 15 (Fig. 1a and Extended Data Fig. 1 ). Proteins mapping to 638 genes were classified as high-confidence interactors. ∆F508 CFTR (Supplementary Data 1) and WT CFTR (Supplementary Data 2) interactomes comprised 576 and 430 proteins, respectively, with an overlap of more than 85% (Fig. 1b, c) . These 638 proteins form the core CFTR interactome, and represent direct as well as indirect CFTR interactors ( Supplementary Tables 1-3 ). An additional 915 interactors with medium confidence scores and at least a ratio of 10:1 over background were further assembled into an extended interactome (Extended Data Fig. 2a ).
Although the majority of proteins (368) in the core interactome interact with both ∆F508 and WT CFTR, 209 differ significantly in the relative amounts recovered. An additional 208 and 62 interactors were detected only in ∆F508 CFTR and WT CFTR CoPIT experiments, respectively, which might represent interactors specific to or at least very highly enriched for either ∆F508 or WT CFTR. Protein expression profiling showed that the vast majority of observed differences between the ∆F508 and WT CFTR interactome are not due to altered expression levels of these proteins in the two cell lines (Extended Data Fig. 2b ). Thus, a ∆F508 CFTR deletion-specific interactome was identified, which is characterized mainly by gain of novel interaction partners ( Supplementary Table 5 ). Alterations in protein networks revealed distinct differences in the biogenesis of WT and ∆F508 CFTR.
Deletion of phenylalanine 508 of the cystic fibrosis transmembrane conductance regulator (∆F508 CFTR) is the major cause of cystic fibrosis, one of the most common inherited childhood diseases. The mutated CFTR anion channel is not fully glycosylated and shows minimal activity in bronchial epithelial cells of patients with cystic fibrosis. Low temperature or inhibition of histone deacetylases can partly rescue ∆F508 CFTR cellular processing defects and function.
A favourable change of ∆F508 CFTR protein-protein interactions was proposed as a mechanism of rescue; however, CFTR interactome dynamics during temperature shift and inhibition of histone deacetylases are unknown. Here we report the first comprehensive analysis of the CFTR and ∆F508 CFTR interactome and its dynamics during temperature shift and inhibition of histone deacetylases. By using a novel deep proteomic analysis method, we identify 638 individual highconfidence CFTR interactors and discover a ∆F508 deletion-specific interactome, which is extensively remodelled upon rescue. Detailed analysis of the interactome remodelling identifies key novel interactors, whose loss promote ∆F508 CFTR channel function in primary cystic fibrosis epithelia or which are critical for CFTR biogenesis. Our results demonstrate that global remodelling of ∆F508 CFTR interactions is crucial for rescue, and provide comprehensive insight into the molecular disease mechanisms of cystic fibrosis caused by deletion of F508.
In particular, we observed enhanced recruitment of specific chaperones such as Hsp90 as well as enhanced protein degradation of ∆F508 CFTR mediated by a protein network, which increased vastly compared with the degradation and ER quality control network for WT CFTR and includes up to 25% of the ∆F508 CFTR specific interactions ( Fig. 1d and Supplementary Table 6 ). While we recovered many of the proteins known to be involved in CFTR degradation, such as AMFR, STUB1 (CHIP) and VCP, we also identified several proteins that have been implicated previously in ERAD of other misfolded proteins but not of ∆F508 CFTR, including AUP1, SEL1L and FAF2 (ref. 16 ). Several of these novel interactions, such as with the lectin-binding protein LGALS3BP and the E3-ligase TRIM21, were confirmed by co-IP followed by western blot detection in bronchial epithelial cell lines and primary bronchial epithelial cells from patients with CF (Extended Data Fig. 2c-g ). In addition, protein interactions implicated in translational control and messenger RNA (mRNA) decay, insertion of proteins into the ER (translocation), N-glycosylation, protein transport and trafficking, anchoring at the plasma membrane, as well as endocytic recycling were strongly altered, suggesting that the entire CFTR biogenesis is affected by deletion of F508. An example of such re-routing is the association of ∆F508 CFTR with the ER quality control component and sugar transferase UGGT, which re-glucosylates unfolded glycoproteins leading to eventual association with ERAD components, or the highly enhanced association of the co-chaperone PTPLAD1 with ∆F508 CFTR. Association of WT CFTR with components of Wnt and mTOR signalling pathways, and of ∆F508 CFTR with proteins involved in TGF-β and JAK/STAT signalling, suggests that cellular signalling is also affected by the F508 deletion. Taken together, these data suggest that the loss of ∆F508 CFTR function emerges from novel associations with multiple alternative protein complexes and cellular pathways that route ∆F508 CFTR differently from WT CFTR.
∆F508 CFTR interactome dynamics at 30 °C
Culture at 26-30 °C promotes formation of fully glycosylated ∆F508 CFTR (band C), incorporation into the plasma membrane and partial restoration of its channel activity 9 . To probe the temporal dynamics of interactions with ∆F508 CFTR and identify the molecular mechanisms that facilitate full glycosylation and lead to functional rescue of ∆F508 CFTR at lower temperature, we monitored changes of the ∆F508 CFTR interactome at different time points during temperature shift to 30 °C (Extended Data Fig. 3a Fig. 2a and Supplementary Data 6) . Changes in the interactome were tightly coupled to the appearance of fully glycosylated ∆F508 CFTR (band C, Fig. 2b ). Although few interactome changes were observed after 1 h at 30 °C, interactions with several proteins involved in ER quality control, such as AIMP1 and AUP1, and in lysosomal targeting (LAMP1) were reduced, and a few new interactions were gained (Supplementary Table 7 ). Long-term incubation at 30 °C abolished 186 (89%) of the 208 unique interactions ( Fig. 2c ) and the interactome was extensively remodelled with more than 65% of all interactions altered. The increased presence of Supplementary Figs 1 and 2 ). Proteins are grouped according to function: (1) protein folding, (2) protein degradation, ER quality control, (3) trafficking (4) protein transport, cytoskeleton, (5) endocytosis, plasma membrane micro-domain organization, (6) signalling, ion transport across membranes, (7) immune response, ROS signalling, (8) metabolism, lipid metabolism, mitochondrial function, (9) uncharacterized, (10) DNA transcription, replication, repair, (11) RNA processing, nuclear import/export, (12) translation, post-translational modification, protein translocation. c, Venn diagram indicates the number of proteins significantly regulated between the WT (green) and ∆F508 CFTR (red) core interactome within different standard errors of measurement (σ) and those detected only in WT or ∆F508 CFTR-IPs. d, Plot depicts the top pathways affected by the ∆F508 mutation and individual regulation of identified CFTR interactors. Pathways are arranged in ascending order of the mean (blue horizontal line). Data are from independent biological replicates, ∆F508 CFTR n = 8, WT CFTR n = 7. TS, temperature shift; PSM, peptide spectrum match; SpC, spectral counts. Article reSeArcH band C was reflected in the interactome as follows: first, by reduced association of ∆F508 CFTR with degradation promoting proteins of ubiquitin-mediated pathways and ERAD, as well as of those involved in endocytic removal of plasma membrane proteins; second, by a more favourable folding environment marked by decreased recruitment of heat-shock proteins (Fig. 2d ); and third, by a marked downregulation of RNA processing (including mRNA decay) proteins such as PABPC1 (33-fold) (Supplementary Tables 7-10).
Reversal of the temperature shift led to loss of fully glycosylated ∆F508 CFTR. However, with only 20 ∆F508 CFTR-specific interactions re-established, the interaction profile still clustered with that of WT CFTR. Interactions that mediated CFTR degradation from either the cell surface or ER, such as E3-ubiquitin protein ligases AMFR (gp78) and STUB1 (refs 17-19) , were re-gained first. Association of ∆F508 CFTR with RAB5B and RAB5A, which are involved in apical endocytosis and recycling, as well as with Erlin1 and Erlin2, which have been implicated in ERAD of IP3 receptors 20 , was also restored. The experiment thus indicated that removal from the plasma membrane and subsequent degradation as well as degradation of newly synthesized ∆F508 CFTR in the ER is responsible for the rapid loss of fully glycosylated ∆F508 CFTR. Taken together, the temperature shift experiment revealed that the association of ∆F508 CFTR with the mutation-specific interactome and consequent alteration of CFTR biogenesis can be suppressed by temperature shift and thus may be responsible for the functional rescue.
Interactome remodelling upon HDACi
Recently, it was reported that inhibition of HDAC activity leads to increased presence of fully glycosylated ∆F508 CFTR and partial functional rescue 13 . Monitoring the interactome upon short interfering RNA (siRNA)-mediated knockdown of HDAC7 (Supplementary Data 7), or treatment with 100 nM trichostatin A (TSA) (Supplementary Data 8) or 5 μ M suberoylanilide hydroxamic acid (SAHA) (Supplementary Data 9) for 24 h, revealed that HDACi induced similar large-scale changes to the ∆F508 CFTR interactome as the temperature shift ( Fig. 3a , Supplementary Tables 11-13 , Supplementary Results and Discussion). More than 75% and almost 90% of interactions affected by TSA or HDAC7 knockdown were also altered by SAHA treatment (Fig. 3b ). In particular, HDACi abolished interactions that were either specific or preferential for ∆F508 CFTR and restored a few WT CFTRspecific interactions ( Fig. 3c ), such as with the proteins NHERF1 and NHERF2, which can act as apical plasma membrane adapters for WT CFTR, and thus probably reflect enhanced ∆F508 CFTR stability at the plasma membrane.
Comparison of the interactions that were affected by temperature shift and HDACi identified trafficking, degradation and mRNA decay pathways required for ∆F508 CFTR rescue and pinpointed distinct differences in the mechanisms by which ∆F508 CFTR rescue is achieved. In contrast to temperature shift, TSA failed to reduce association with several protein disulfide isomerases that are involved in ER quality control. SAHA treatment even enhanced association with ERAD component SEL1L, with E3-ligase SUGT1 and E3C ligase (UBE3C), which enhances proteasome processivity 21 . We also identified additional lysosomal degradation proteins such as cathepsin B and TPP1 in the SAHA interactome, probably reflecting failure of SAHA to fully prevent retrotranslocation and degradation of ∆F508 CFTR. Additionally, HDACi induced extensive changes to the ∆F508 CFTR-associated cytoskeleton, which appear to have wide-ranging influence on anterograde and retrograde transport. Despite these changes to the interactome, the interaction profiles of ∆F508 CFTR upon treatment with HDACi or Cmpd 4a clustered with the interaction profile of control ∆F508 CFTR rather than with WT CFTR (Extended Data Fig. 3b ). Further differences Relative fold change R Article reSeArcH between temperature-shift-and HDACi-mediated rescue included an inversely altered association of chaperone HSP70 and HSP90 family members with ∆F508 CFTR (Fig. 3d ). While temperature shift only slightly affected association of ∆F508 CFTR with the HSP70 and Hsc70 chaperone machinery (1.35-fold less), it strongly reduced the association of ∆F508 CFTR with Hsp90 proteins (6.2-fold less). Conversely, HDACi strongly reduced the association of ∆F508 CFTR with detected Hsp70 family members (3.4-fold less) and affected association with Hsp90 proteins to a lesser degree (2.5-fold less). Reduced binding of chaperones to ∆F508 CFTR was independent of chaperone expression levels, which were either not influenced or upregulated by temperature shift or HDACi 13 (Extended Data Fig. 3c ). However, enhanced acetylation of heat-shock proteins may lead to remodelling of the chaperone environment and may disrupt the heat-shock-ubiquitin-proteoasome pathway, which controls mRNA decay 22 . ∆F508 CFTR mRNA decay is possibly the pacemaker for the CF phenotype, as all treatments that induced ∆F508 CFTR rescue downregulate the association of a distinct set of more than 30 proteins that affect mRNA stabilization and decay, including PABPC1, YBX1 and UPF1. Interestingly, a subset of seven ∆F508 CFTR-specific interactions was not corrected either by temperature shift or by SAHA. This subset included members of the 26S proteasome (PSMC1, PSMD11), which induce protein aggregation and neuro-degeneration if inhibited in their function 23, 24 , and PSMB8, a stress-inducible subunit of the 20S core proteasome 25 , as well as the two co-chaperones BAG3 and DNAJB2. DNAJB2 inhibition leads to partial ∆F508 CFTR rescue 19 . BAG3, whose binding to ∆F508 CFTR was significantly upregulated immediately after temperature shift, mediates aggresome formation and selectively induces autophagy of misfolded proteins 26 . Persistence of these interactions suggests that these proteins detect ∆F508 CFTR and channel it to autophagy and proteasomal degradation, even under rescuing conditions. SURF4 has been implicated in vesicular trafficking 27, 28 and store-operated Ca 2+ entry 29 , whereas the molecular function of the last member of this subset, ERH, has remained enigmatic, but may be associated with RNA splicing 30 .
Interactor RNA interference restores ∆F508 function
To assess the potential of rescuing the ∆F508 CFTR phenotype by blocking novel protein-protein interactions identified in this study, we performed an RNA interference (RNAi) screen with validated short hairpin RNAs (shRNAs) and monitored ∆F508 CFTR maturation and its glycosylation pattern by electrophoresis as a measure of rescue. A total of 52 proteins were selected (Extended Data Fig. 4 ) and tested including HDAC2 as positive and CSNK2A as negative controls. Knockdown of 6 proteins had minor to no effect, knockdown of 17 proteins led to reduced ∆F508 CFTR stability and yield, Article reSeArcH and knockdown of 31 interactors promoted ∆F508 CFTR maturation ( Fig. 4a and Extended Data Fig. 5 ). Many of the 31 novel interactors might sequentially control ∆F508 CFTR protein production and turn over as they belong to (1) a network associated with mRNA decay and co-translational control, (2) complexes affecting ∆F508 CFTR trafficking and endocytic recycling, (3) ER quality control and folding or (4) the protein degradation network ( Fig. 4b ; see also Supplementary Results and Discussion). The subcellular interaction of ∆F508 CFTR with the top sub-networks or complexes was spatially resolved by co-immunostainings of nine binding partners that represent different cellular compartments according to Gene Ontology ( Fig. 4c and Extended Data Fig. 6a-c) . Prolyl-4-hydroxylase (P4HB), an ER and plasma membrane marker, PDIA4, which recognizes unfolded protein regions 31 , and PTPLAD1, which exhibits Hsp90 co-chaperone activity 32 , co-localized with ∆F508 CFTR in the ER. Co-staining was also observed with SURF4, which is found in the early secretory pathway, ERGIC and Golgi 28 , as well as with the GTPase RASEF, which is potentially involved in membrane trafficking. Co-staining of ∆F508 CFTR with KLHDC10 and TRIM21, which are involved in degradation 33, 34 , and with PABPC1, which is involved in RNA processing [35] [36] [37] , was observed in the nuclear periphery. LGALS3BP, which is part of the KLHDC10-FAF2 degradation complex 38 and which negatively influenced ∆F508 CFTR stability, only partly colocalized with ∆F508 CFTR in vesicular structures.
To evaluate further the therapeutic potential of interactors that influenced ∆F508 CFTR maturation in CFBE41o− cells in the RNAi screen, we assessed rescue of ∆F508 CFTR channel function for eight interactors that bind preferentially to ∆F508 CFTR and/or were dynamically regulated by temperature shift and HDACi. Interactors represent either the RNA decay and co-translational control network (PABPC1, PTBP1, YBX1), or the degradation network (LGALS3BP, TRIM21) or are potential novel components of ER quality control (PDIA4, SURF4, PTPLAD1). Primary human bronchial epithelial cells from healthy donors or patients with CF, and CFBE41o− cells, were differentiated into epithelial cultures at an air-liquid interface (ALI) and ∆F508 CFTR channel function was determined by electrophysiology in an Ussing chamber ( Fig. 5a ).
Knockdown of seven interactors enhanced forskolin/genisteinstimulated ∆F508 CFTR channel activity at the apical plasma membrane up to 12-fold over controls in primary CF epithelia and by about 4.5-to 7-fold in CFBE41o− epithelia, which is comparable to rescue by temperature shift (Fig. 5b, c 
WT Article reSeArcH blot, knockdown of seven of the eight interactors also led to a clearly visible ∆F508 CFTR signal in the primary ALI cultures after differentiation for 28 d and induced band C formation similar to temperature shift, which correlates well with the increase in ∆F508 CFTR channel activity observed in the Ussing chamber measurements (Extended Data Fig. 7 ). In the case of LGALS3BP knockdown, no CFTR signal was detected in primary CF bronchial epithelial cells by western blot and we failed to detect ∆F508 CFTR-specific chloride current in CFBE41o− epithelia or primary CF bronchial epithelia. Loss of ∆F508 CFTR in CFBE41o− cells that constitutively express an LGALS3BP shRNA (clone 13) showed that LGALS3BP is critical for ∆F508 CFTR stability. Furthermore, no CFTR chloride channel activity was measured upon LGALS3BP knockdown in a halide-sensitive yellow fluorescent protein (YFP) assay, whereas upon stable knockdown of PTPLAD1 (clone 24), CFTR chloride channel function was greater than in parental CFBE41o− cells (Extended Data Fig. 8 ). Our results show that reduction of protein levels of seven interactors rescues channel function of ∆F508 CFTR and thus we conclude that modulation of interactors might be a promising route to correction of the ∆F508 CFTR defect.
Closing remarks and outlook
The CoPIT results established a comprehensive interactome for WT as well as ∆F508 CFTR in epithelial airway cells, defined disease-specific alterations and revealed interactome dynamics upon temperature shift and intervention by HDACi. The number of proteins obtained for the CFTR core interactome with CoPIT (638) can be rationalized by the identification of direct and indirect interactors of CFTR (secondand third-degree interactions) and reflects the complicated multi-step biogenesis of membrane proteins in mammalian cells as well as the number of different possibilities of a cell to cope with misfolded CFTR protein. ∆F508 alters CFTR translation, folding, insertion into the ER and trafficking, and enhances its degradation, overall contributing to an increased number of direct and indirect interactors compared with WT CFTR. Thus, CoPIT analysis of the CFTR interactome shows that the disease phenotype CF is a direct consequence of the derailment of a whole network of protein interactions in the presence of the ∆F508 mutation. Intriguingly, many of the proteins that bind differentially to WT and ∆F508 CFTR have been implicated in other misfolding or protein aggregation diseases as well, as revealed by querying the Online Mendelian Inheritance in Man (OMIM) database 39 and UniprotKB 40 .
In particular, we noticed differential binding of proteins to CFTR that are implicated in neurodegenerative diseases (Extended Data Fig. 9 ), suggesting similar disease mechanisms. Although we can only speculate, the mechanisms that lead to ∆F508 CFTR destabilization and clearance could be tentatively harvested to achieve clearance of toxic protein aggregates or to stabilize other misfolded proteins that display a loss of function phenotype such as ∆F508 CFTR.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Primary bronchial epithelial cells or CFBE41o− cells were infected with shRNA lentivirus, seeded onto Snapwell culture inserts and cultured at air-liquid interface for 28-30 days, before measuring short-circuit currents in an Ussing chamber. b, Representative traces of forskolin (10 μ M) and genistein (50 μ M) activated ∆F508 CFTR short-circuit current (I sc ). c, Quantification of the peak CFTR Inhibitor 172 (Inh 172)-sensitive I sc (∆I sc ) in CFBE41o− cells (n = 3-5) and in human primary CF bronchial epithelial cells (DHBE, n = 2-5) as fold change relative to non-target shRNA (NT sh) following knockdown of indicated interactors. Error bars, mean ± s.e.m.
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MethOdS Cell lines and cell culture. Human bronchial epithelial cells (CFBE41o−) carrying the ∆F508 CFTR mutation, or HBE41o− cells harbouring a WT CFTR allele, and isogenic CFTR null cells (CFBE41o−, null) were provided by J. Clancy. Cells were cultured at 37 °C, 5% CO 2 in Advanced MEM (Gibco) supplemented with 1% penicillin/streptomycin (Gibco), 10% fetal bovine serum (Gibco) and 2 mM l-glutamine (Gibco) and appropriate selective antibiotics. Twenty hours before IP, cells were treated with DMSO (vehicle) or DMSO and 100 nM TSA (Sigma-Aldrich), 5 μ M SAHA (Cayman Chemicals), 15 μ M N-[2-(5-chloro-2methoxyphenylamino)-4′ -methyl-[4,5′ ]bithiazolyl-2′ -yl]-benzamide (Cmpd 4a, C4, Cystic Fibrosis Foundation, http://www.cftrfolding.org/CFTReagents.htm). For siRNA-mediated knock down of HDAC7, CFBE41o− cells were transfected with Lipofectamine RNAiMAX (Invitrogen) and 50 nM of validated HDAC7specific siRNA (Ambion) or scrambled control siRNA (Ambion) according to the manufacturers' protocol. The cell culture medium was changed the next day and cells harvested 72 h after transfection. Primary bronchial epithelial cells were obtained from the Cystic Fibrosis Center at the University of Alabama according to institutional review board regulations or from Lonza, and were cultured in complete BEGM medium (Lonza) at 37 °C, 5% CO 2 for up to three passages, starting with passage 0. Cell lines were tested for mycoplasma contamination with DAPI staining and their identity validated based on presence of the correct CFTR alleles as determined with polymerase chain reaction (PCR) and mass spectrometry. Cell culture experiments as well as subsequent sample processing and mass spectrometric data-taking were randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Lentiviral-mediated knockdown of target proteins. Lentiviral particles containing shRNA sequences specific for the target proteins were generated in HEK293T cells using the Mission shRNA system with validated shRNA sequences (Sigma-Aldrich) following standard protocols 41 . CFBE41o− cells were infected with lentiviral particles for 16 h and cultivated for additional 48 h before harvest. Lentivirus production and infection is covered under approval 01-13-10-07 from The Scripps Research Institute and all steps were performed in a biosafety level 2/3-certified laboratory. Rescue of ∆F508 CFTR was monitored by western blotting followed by immunodetection of CFTR using rat monoclonal 3G11 antibody. The RNAi Consortium identification numbers for the shRNAs used are given in Supplementary Table 15 . Western blotting and immunofluorescence. Protein lysates were prepared as described above, denatured in SDS sample buffer 42 either for 15 min at 37 °C to detect CFTR or for 5 min at 95 °C, separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose (Protran; Schleicher & Schuell). The following primary antibodies were used: rat monoclonal antibody against CFTR (3G11), mouse monoclonal antibodies against CFTR (24.1, ATCC; M3A7, Chemicon) and β -actin (AC-15, Sigma), rabbit polyclonal antibodies against HDAC2 (9928S, Cell Signaling), PABPC1 (ab21060, Abcam), anti-galectin-3BP (AF2226, R&D Systems), anti-PTPLAD1 (WH0051495M1, Sigma), anti-52 kDA Ro/SSA (sc-25351, Santa Cruz) and anti-Na + /K + ATPase α Antibody (H-300, sc28800, Santa Cruz). Horseradish-peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch) were detected with enhanced chemiluminescence reagent (ECL, Pierce). For immunofluorescence, CFBE41o− cells fixed with 4% paraformaldehyde were permeabilized with 0.1% Triton X100, blocked in 10% FBS in 1× PBS for 1 h at room temperature (21 °C) Measurements were performed at 37 °C and the short-circuit current (I sc ) was recorded and analysed with Acquire and Analyze 2.0 (Physiological Instruments).
CoPIT co-IP and sample preparation for multidimensional chromatography (LC/LC)-MS/MS. The detailed
CoPIT protocol is available on the Nature protocol exchange website 44 .
Rat monoclonal anti-CFTR antibody (3G11) was coupled to Protein G Sepharose 4 Fast Flow beads (GE Healthcare) at 6 mg ml −1 packed beads and covalently crosslinked to the beads with 20 mM dimethylpimelimidate (DMP, Pierce). CFBE41o− or HBE41o− cells from passages 5 to 19 were grown to confluence in Advanced MEM supplemented with 10% FCS, 1% penicillin/ streptomycin, 2 mM l-glutamine and additional appropriate antibiotics. Approximately 4 × 10 7 or ~1 × 10 8 cells were harvested per IP, rinsed with PBS, lysed, CFTR protein complexes immunoprecipitated and prepared for MS analysis according to the CoPIT protocol. Briefly, cells were lysed on ice in TNI-buffer (0.5% Igepal CA-630 (Sigma-Aldrich), 50 mM Tris pH 7.5, 250 mM NaCl, 1 mM EDTA and 1× Complete EDTA-free Protease Inhibitor mix (Roche)). After water-bath sonication, insoluble material was removed by centrifugation (30 min, 18,000g, 4 °C) and the supernatant pre-cleared by incubation with Sepharose CL-4B (GE Healthcare). The pre-cleared lysate was then incubated overnight at 4 °C with 50 μ l (approximately 250 μ g) of anti-CFTR 3G11 antibody covalently coupled to Protein G Sepharose. Immunoprecipitates were recovered by centrifugation (500 g, 5 min, 4 °C), washed three times with lysis buffer and twice with lysis buffer containing no detergent. Bound proteins were eluted twice with 0.2 M glycine pH 2.3 and 0.5% Igepal CA-630 (30 min, 37 °C) and precipitated (eluate:methanol:chloroform, 1:4:1, v:v:v). The precipitate was washed with 95% methanol and re-solubilized in 100 mM Tris pH 8.5 and 0.2% Rapigest (Waters). Samples were reduced with 5 mM TCEP (Pierce), alkylated with 10 mM iodoacetamide (Pierce) and proteins digested overnight with 3 μ g of sequencing-grade recombinant trypsin (Promega). Formic acid (9% final, v-v) was added to inactivate Rapigest (2 h, 37 °C), any precipitate removed by centrifugation (15 min, 18,000g at room temperature), and samples reduced to near dryness in vacuo. To identify non-specific contaminating proteins, control IPs were performed from (1) isogenic CFTR null cells to identify background that is recognized by the 3G11 antibody and (2) by using mock-IPs, in which no antibody is coupled to the beads, to identify bead-and cell-specific background. Expression profiling. Protein lysates from CFBE41o− and HBE41o− cells at the same passage number were prepared in TNI lysis buffer, precipitated (lysate:methanol:chloroform (1:4:1, v:v:v) and 100 μ g of protein reduced, alkylated and digested with trypsin as described above. Resulting peptides were labelled with 6-plex Tandem Mass Tag (TMT) labelling reagent (Thermo-Fisher) according to the manufacturer's recommendations. Subsequently, Rapigest was inactivated by acidification with 10% formic acid, insoluble precipitate removed by centrifugation (15 min, 18,000g) and samples reduced to near dryness in vacuo. LC/LC-MS/MS. Samples were analysed by nano-electrospray ionization (ESI)-LC/LC-MS/MS on an LTQ-Orbitrap XL, LTQ or Orbitrap Elite (Thermo Fisher) by placing the triphasic MudPIT column in-line with an Agilent 1100 quaternary HPLC pump (Agilent) and separating the peptides in multiple dimensions with a modified six-step gradient containing 0%, 20%, 40%, 60%, and 100% of buffer C (500 mM ammonium acetate/5% acetonitrile/0.1% formic acid) over 12 h with the last step (100%) repeated, or a ten-step gradient (0%, 10%, 20%, 30%, 40%, 50%, 70%, 80%, 90%, 100% buffer C) over 20 h as described previously 45 .
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Each full-scan mass spectrum (400-2000 m/z) was followed by 6 (LTQ, LTQ-Orbitrap XL,) or 20 (Orbitrap Elite) data-dependent MS/MS scans at 35% normalized collisional energy and an ion count threshold of 1,000 (LTQ-Orbitrap XL, Orbitrap Elite) or 500 counts (LTQ). Dynamic exclusion was used with an exclusion list of 500, repeat time of 60 s and asymmetric exclusion window of −0.51 and +1.5 Da. To avoid cross-contaminations between the different samples, each sample was loaded onto a fresh column. CoPIT data analysis. Raw files were extracted with RawExtract (fields.scripps.edu/ researchtools.php) and MS/MS spectra searched with ProLuCID 46 against the human International Protein Index database version 3.23, using a target-decoy approach in which each protein sequence was reversed and concatenated to the normal database 47 . Search parameters were set to no enzyme specificity, 50 p.p.m. precursor mass tolerance and carboxyamidomethylation (m = 57.021464 Da) as a static modification. Search results were filtered with DTASelect version 2.1 (ref. 48) , allowing for tryptic peptides only and a peptide false discovery rate of less than 0.5%, usually corresponding to a protein false discovery rate of less than 1.0%. To uniformly control the false discovery rate across samples in CoPIT, and to facilitate comparison, sqt files of replicate samples were filtered in a single DTASelect run and split again in corresponding replicate subsets for further analysis. Samples with non-sufficient recovery of the bait (< 35 spectral counts) were excluded from further analysis. To remove redundancy due to isoform-specific identifiers, which is problematical for statistical analysis, International Protein Index numbers were first converted to Entrez Gene symbols using the X-REF Converter developed by RIKEN (http://refdic.rcai.riken.jp/tools/xrefconv.cgi) and manual annotation based on the Ensembl release 43 (http://www.regulatorygenomics.org); the highest PSM (peptide-spectrum match) values of all protein variants per gene and experiment were retained. CoPIT assumes that proteins binding non-specifically and non-selectively to carrier or antibody are detected with equal likelihood in experimental conditions (e) and control (c), as shown previously 49, 50 . Ratios for proteins p were calculated as = (∑ / ∑ ) = = r log P SM PSM i n i i n i p e c 10 1 p e 1 p c , where n is the number of experiments. Data were then plotted in Matlab, and a bimodal model was applied to analyse the frequency distribution of all ratios r pec and fitted with a Gaussian of two where σ bg , μ bg , σ sp and μ sp were derived from the respective terms of the Gaussian fit. Proteins that were identified only in background control samples were eliminated from the analysis as obvious background contaminants. For a protein to be considered a potentially true interactor, we required further that it be detected in at least two independent biological replicates of the same condition to minimize random sampling errors and identities. Fold change of a protein p between two different experimental conditions was calculated according to ; wherein r p is the average relative ratio of the protein and σ r p is the random error of measurement.
Annotation data were derived from Uniprot Knowledge Base, Entrez Gene information, GO Miner and literature review on PubMed. Interactions between the identified interactors were obtained with the GeneMANIA 2.2 Plugin 51 in Cytoscape 2.8.2 using physical interactions reported in BIOGRID-small scale studies, BIOGRID and BIND as well as Pathway information reported in Pathway Commons. Proteins, their connections and according functional annotation were then graphed in Radial Topology Viewer 0.6, which was based on Medusa 52 , whereby length of individual edges reflects a quantitative relationship with the bait such as enrichment over background.
Analysis of additional small networks was performed using Osprey 1.2.0 (ref. 53) and Ingenuity Pathway Analysis (Ingenuity). Analysis of the expression profiling experiments was performed in Census and the Integrated Proteomics pipeline IP2 (Integrated Proteomics Applications) using the TMT option with a tolerance of 10 millidaltons and a minimum intensity threshold of 100,000 relative ion counts 54 . Statistical significance was determined with an unpaired t-test for differential expression (two-tailed and two-sample t-test on every protein). The volcano plot was generated with the biostatistics package in Matlab (Mathworks). The data set was uploaded to Proteomics INTegrator (PINT; S.M.-B., unpublished observations) for online accession at http://sealion.scripps.edu/pint? project= CFTR ('CFTR' data set). It includes all qualitative and quantitative data over all experimental conditions and replicates measured. In addition, PINT provides an advanced query and annotation system, including the retrieval of Uniprot annotations assigned to the proteins in the data set. CFTR core interactome hierarchical clustering analysis. The CFTR interaction profile of a given condition was represented by log 10 -transformed ratios of core interactome protein abundances (sum of spectral counts across the replicates of that condition) and the abundance value of CFTR in that same condition. Hierarchical clustering of the different conditions was produced using the average linkage algorithm. The distance between two conditions was set to one minus their Pearson correlation. Heat-map representation was produced using gplots version 2.14.1, and bootstrap values were obtained using the R package pvclust 1.2-2 (ref. 55 ). The colour and relative distance to CFTR in the centre reflect the confidence P of an identified protein to be a specific CFTR interactor. Left: no filters were applied and all recovered proteins from the IPs are depicted. Right: core interactome of ∆F508 CFTR (P > 0.92). Distance and colour indicate the confidence of an identified protein to be a specific CFTR interactor. b, Overlay of the interactome data with protein expression profiling data shows that observed interactome differences between WT and ∆F508 CFTR are unrelated to expression changes between HBE41o− and CFBE41o− cells. The volcano plot displays the fold change and log 10 (P) for 4,563 proteins quantified with tandem mass tag (TMT) in the expression profiling experiment. Core interactors of CFTR (529 proteins) that were not differentially regulated between the two cell lines are displayed in blue whereas significantly altered core interactors (r ≥ two-fold, P < 0.01) are displayed in red. LGALS3BP GIPC1  PPP1R13L  KDELR1  KDELR2  KDELR3  TRIM29  QPCT  FAF2  KLHDC10   C  B/A   scr  HDAC2  CSNK2A1  PABPC1  PTBP1  UPF1  SET  TRIM21  PABPC4  YBX1  PDIA4   scr  HDAC7  TRIM29  QPCT  FAF2  KLHDC10  PTPLAD sh1  PTPLAD sh2  SURF4  RASEF   C  B/A   HDAC2   CFTR   PABPC1   wt  I  scr  PRKCSH  ISG15  SAE1  SAP18  MAT2A  SIRT2  TNRC6B  SIN3B I  scr  GANAB  CTSD  SORCS1  PICALM1  ARCN1  ANKRD13   TBCD  UGGT1   wt  scr  CHUK  STK3  GGCT  ERH  TNS3  YBX1   wt  I  scr  UBR3  AIMP1  ATAD3  C9orf167  C9orf167  UBR4  SRP14  SRP14   wt  I  scr  HSPB1  TBCD  PARK7  PICALM 

